Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2025-12-29 @ 1:23 PM
Study NCT ID:
NCT07161193
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-08
First Post:
2025-08-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases
Sponsor:
Hebei Senlang Biotechnology Inc., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-08-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11-18
Completion Date Type:
ESTIMATED
First Submit Date:
2025-08-19
First Submit QC Date:
None
Study First Post Date:
2025-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-03
Last Update Post Date:
2025-09-08
Last Update Post Date Type:
ESTIMATED